New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 12, 2009
07:07 EDTALNY
theflyonthewall.com: Alnylam Pharmaceuticals issues update on RNAi pipeline
Alnylam Pharmaceuticals is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today. Alnylam scientists and management will be joined by two guest speakers: Professor Allan Glanville, Director of Thoracic Medicine and Medical Director Lung Transplantation, St. Vincent’s Hospital, Sydney, will discuss respiratory syncytial virus infection in the lung transplant patient population; and Professor Philip N. Hawkins, National Amyloidosis Centre, Division of Medicine, and University College London Medical School, Royal Free Hospital, will discuss transthyretin-mediated amyloidosis. Alnylam is developing RNAi therapeutics for the treatment of both RSV infection and ATTR, amongst other pipeline programs. :theflyonthewall.com



News For ALNY From The Last 14 Days
Check below for free stories on ALNY the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2012
08:06 EDTALNY
theflyonthewall.com: Alnylam scientists discovery novel method for monitoring RNAi activity
Alnylam Pharmaceuticals announced that its scientists have discovered a novel method for monitoring RNAi activity in blood samples, representing a potential major advance for future development of RNAi therapeutics, other therapeutic modalities, and diagnostics. This new method, called “circulating extracellular RNA detection," allows quantitative measurement of tissue-specific mRNA silencing from biological fluids including blood and cerebrospinal fluid. Alnylam intends to enable use of the new technology in academic research and license industry to deploy the technology. :theflyonthewall.com

January 30, 2012
08:07 EDTALNY
theflyonthewall.com: Alnylam gets patent for second generation LNP for delivery of RNAi therapeutics

Subscribe for More Information
:theflyonthewall.com